Nanosphere Health Sciences Inc
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences … Read more
Nanosphere Health Sciences Inc (NSHSF) - Total Liabilities
Latest total liabilities as of September 2025: $1.39 Million USD
Based on the latest financial reports, Nanosphere Health Sciences Inc (NSHSF) has total liabilities worth $1.39 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nanosphere Health Sciences Inc - Total Liabilities Trend (2005–2024)
This chart illustrates how Nanosphere Health Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nanosphere Health Sciences Inc Competitors by Total Liabilities
The table below lists competitors of Nanosphere Health Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
The Shyft Group Inc
F:SP8
|
Germany | €333.76 Million |
|
COGNEX - Dusseldorf Stock Exchang
DU:CGZ
|
Germany | €496.22 Million |
|
New Tymbal Resources Ltd.
V:NTB
|
Canada | CA$6.08 Million |
|
Marine Bancorp of Florida Inc
PINK:MBOF
|
USA | $590.02 Million |
|
Multifiling Mitra Indonesia
JK:MFMI
|
Indonesia | Rp361.19 Billion |
|
BEKAERT - Dusseldorf Stock Exchang
DU:BK8N
|
Germany | €1.92 Billion |
Liability Composition Analysis (2005–2024)
This chart breaks down Nanosphere Health Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 85.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanosphere Health Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanosphere Health Sciences Inc (2005–2024)
The table below shows the annual total liabilities of Nanosphere Health Sciences Inc from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.23 Million | -21.83% |
| 2023-12-31 | $1.57 Million | +14.76% |
| 2022-12-31 | $1.37 Million | +13.57% |
| 2021-12-31 | $1.21 Million | -19.95% |
| 2020-12-31 | $1.51 Million | +20.41% |
| 2019-12-31 | $1.25 Million | +160.34% |
| 2018-12-31 | $481.37K | +187.56% |
| 2017-12-31 | $167.40K | -29.21% |
| 2016-12-31 | $236.48K | -12.47% |
| 2015-12-31 | $270.15K | +17.34% |
| 2014-12-31 | $230.22K | -51.25% |
| 2013-12-31 | $472.24K | -6.27% |
| 2012-12-31 | $503.86K | +83.44% |
| 2011-12-31 | $274.67K | +231.65% |
| 2010-12-31 | $82.82K | +446.03% |
| 2009-12-31 | $15.17K | -92.25% |
| 2008-12-31 | $195.61K | -85.97% |
| 2007-12-31 | $1.39 Million | +12799.33% |
| 2006-12-31 | $10.80K | +93.06% |
| 2005-12-31 | $5.60K | -- |